SYS-CON MEDIA Authors: RealWire News Distribution, Kevin Benedict, Jason Bloomberg, David H Deans, Gilad Parann-Nissany

News Feed Item

Pharmaceuticals and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325412

NEW YORK, March 25, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceuticals and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325412
http://www.reportlinker.com/p02017106/Pharmaceuticals-and-Drug-Manufacturing-Industry-US-Analytics-Extensive-Financial-Benchmarks-Metrics-and-Revenue-Forecasts-to-2020-NAIC-325412.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

Pharmaceuticals and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325412

Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research.

Core Benefits to Customer:
1) Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package
2) Complete benchmarking of the industry and its top companies
3) Deep industry and company financials

This Plunkett Analytics Report Features:
1) Historical data
2) Revenue forecasts, growth rates and CAGR
3) Operating ratios
4) Complete data for benchmarking a company to its industry and to specific leading companies
5) Benchmarking this industry to all U.S. industries
6) Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies

Pages: 74
Statistical Tables Provided: 33
Charts Provided: 21
Geographic: US

Designed to benefit:
• Analysis and Financial Modeling
• Investment Professionals
• Lenders
• M&A Advisors
• Appraisers
• Consultants

Similar reports are available from Plunkett Research for nearly all U.S. industries.

"Plunkett Research has built a solid reputation providing industry analysis and research in a diverse spectrum of areas—energy and utilities, finance and investment, health care and biotechnology, and engineering and research to name a few." American Reference Books Annual

Key Data:

Industry Summary
• Revenues historical through 2013
• Revenues projected through 2020
• Employee Count 2007-2013
• Annual Growth Rate 2013
• CAGR 2005 through 2013
• CAGR 2013 through 2020
• Top U.S. Companies


Employment and Establishments
• Number of Firms 2007-2013
• Number of Establishments 2007-2013
• Employees, 2007-2013
• Average Annual Sales per Firm & per Establishment 2007-2013
• Sales per Employee

Average Annual Operating Ratios
• Revenue Compared to All Industries
• Expenses Compared to All Industries
• Profits & Income Taxes Compared to All Industries

Benchmarks

This Industry Compared to All Industries

• Comparison of Revenues, Profits and Taxes to All Industries

Industry Results, Publicly-Held Companies (U.S.), Average for all Companies
• Industry Income Statement, Balance Sheet, Cash Flow Statement, 2007-2012

Top Companies Profiled & Ranked
In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations

Top Companies Ranked
• Market Capitalization 2014
• Employees
• Revenue
• Net Income
• 3-Year Revenue Growth
• 3-Year Income Growth
• Return on Assets
• Return on Equity
• Return on Invested Capital

List of Leading (Public and Private) Companies

Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2012
• Income Statements. Balance Sheets and Cash Flow Statements


Companies Profiled:
• Johnson & Johnson
• Pfizer Inc
• Merck & Co Inc
• Abbott Laboratories
• Eli Lilly & Company
• Bristol-Myers Squibb Co
• Amgen Inc
• Genentech Inc
• Gilead Sciences Inc GILD
• Mylan Inc

Introduction
Core Benefits to Customer:
• Comprehensive overview of an industry's financial results, ratios, vital metrics in one package
• Benchmarking of:
• a) deep financials of each of the leading companies
• b) financial averages for all companies
• c) this industry's ratios to all other industries
• Historical revenues, enterprises and sales per employee
• Current and forecast revenues and CAGR to 2020
• Profiles of leading companies

Industry Description for this NAIC Code
• Types of business activities

Industry Summary, Current Data
• Revenues 2013
• Revenue forecast to 2020 with CAGR
• Historical revenues and CAGR
• CAGR, historic, through 2013
• Top U.S. companies, by revenues
• Employment, 2013 and historic

Employment and Establishments
• Number of firms and establishments, 2007-2013
• Employees, 2007-2013, with growth rates
• Average annual sales per firm & per establishment, 2007-2013
• Annual sales per employee, 2007-2013

Industry Financial Data, U.S., With Revenue Projections to 2020

Revenues, Historical and Projected
• Historical revenues & annual growth rates, 2005-2012
• Projected revenues & annual growth rates, 2013-2020

Average Annual Operating Ratio Estimates, Current
• Income items, expenses, profits and taxes as a percent of total revenues for this industry compared to all industries

Benchmarks

This Industry Compared to All Industries, Current
• Comparison of revenues for all U.S. companies within this industry to all industries
• Comparison of EBITDA, profits & income taxes for all companies within this industry to all industries

Companies Used in Creating This Study
Alphabetical list of leading companies, with details

Industry Results, Publicly-Held Companies
• Income statement averages, 2007-2012
• All income statement items, including, cost of sales, SGA, R&D, salaries and wages, EBITDA, with ratios
• Chart showing key expenses as a percent of revenues
• Balance sheet averages, 2007-2012
• All items, including property plant and equipment, accumulated depreciation, goodwill, long term debt, including ratios
• Cash flow averages, 2007-2012
• All cash flow items

Top Companies Profiled & Ranked
In-depth profiles, financial reports, ranks & executive lists for up to 10 top U.S.-based corporations

Top Companies Ranked
Company ranks:
• Approximate market capitalization 2014
• Employees
• Revenues
• Net income
• 3-Year revenue growth (%)
• 3-Year income growth (%)
• Return on assets (%)
• Return on equity (%)
• Return on invested capital (%)

Comparison of Top Publicly-Held Companies to Industry Averages, 2012
• Income statements, balance sheets and cash flow statements for each of the top companies compared to the overall industry average

Top Companies, Profiles and Financials
• Contact information, executive lists
• Business descriptions
• Key financial data for 6 years
• Brands and divisions
• Top salaries
• Corporate culture
• Charts comparing revenues vs. net income

Appendix: Assumptions
• U.S. GDP Growth and Forecasts, 2011-2020
• U.S. Total National Health Care Expenditures & Annual Percent Change and Forecast, 2012-2020
• U.S. Prescription Drugs Expenditures & Annual Percent Change and Forecast, 2012-2020

Data Description and Sources

Companies Mentioned

• Johnson & Johnson
• Pfizer Inc
• Merck & Co Inc
• Abbott Laboratories
• Eli Lilly & Company
• Bristol-Myers Squibb Co
• Amgen Inc
• Genentech Inc
• Gilead Sciences Inc GILD
• Mylan Inc

To order this report: Pharmaceuticals and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325412
http://www.reportlinker.com/p02017106/Pharmaceuticals-and-Drug-Manufacturing-Industry-US-Analytics-Extensive-Financial-Benchmarks-Metrics-and-Revenue-Forecasts-to-2020-NAIC-325412.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.